Jasdeep Mann is a Senior Director at Eli Lilly, overseeing advancements in protein engineering and cellular therapies. With over 12 years of experience in areas such as gene editing and immunotherapy, they have successfully led multidisciplinary teams in developing therapies targeting hematological malignancies and solid tumors. Educated at prestigious institutions, including a Ph.D. from the State University of New York at Buffalo, Jasdeep has contributed to numerous publications and patents in their field. Their previous roles included leadership positions at Notch Therapeutics and bluebird bio, where they targeted innovative approaches in oncology and gene therapy.
This person is not in the org chart
This person is not in any teams
This person is not in any offices